Ernst Schaefer

Overview

Dr. Schaefer is internationally recognized as a leader in the field of lipoprotein metabolism and the diagnosis and management of lipoprotein disorders for the prevention of Coronary Heart Disease. He has made countless contributions to the National Cholesterol Education Program (NCEP) of the National Institutes of Health (NIH) and is a member of the National Lipid Association s (NLA) Board of Directors.Dr. Schaefer founded Boston Heart Diagnostics Corporation with Dr. Bela Asztalos and Peter Parker in 2007 after developing the company s proprietary HDL measurement technology and the Boston Heart Cholesterol Balance test. They established HDL particle concentration as a more effective predictor for coronary heart disease (CHD) risk than traditional tests and documented the utility of plasma sterol measurements to guide physician therapy to get patients to their LDL cholesterol goals. Dr. Schaefer is internationally recognized as a leader in the field of lipoprotein metabolism and the diagnosis and management of lipoprotein disorders for the prevention of CHD.